The publications included herein are either authored or sponsored by Novartis Gene Therapies. As such, the publications included may not represent all publications that are available in the public domain. For a comprehensive list of citations for biomedical literature, please refer to PubMed.gov.

By clicking on the links, you are attesting that this is an unsolicited request for information. You can narrow your publication by utilizing the topics on the left. The .pdf copies are subject to the US Sunshine Act reporting and requires health care provider registration.

Clinical Trials – include publications on ZOLGENSMA registration-enabling studies

Safety and Treatment Considerations – include publications on ZOLGENSMA’s safety and other considerations affecting treatment

Other Publications – include publications on comparative data, clinical study subanalyses and special populations, and review publications

Gene Therapy – include publications on gene therapy

The scientific information may include data/information on investigational use(s) of compounds/drugs for which efficacy and safety have not been established. Information available on this website is not intended to promote or otherwise commercialize (directly or indirectly) any off-label or unapproved uses of Novartis products.